TY  - GEN
AU  - Basu,B
AU  - Vitfell-Pedersen,J
AU  - Moreno Garcia,V
AU  - Puglisi,M
AU  - Tjokrowidjaja,A
AU  - Shah,K
AU  - Malvankar,S
AU  - Anghan,B
AU  - de Bono,J S
AU  - Kaye,S B
AU  - Molife,L R
AU  - Banerji,U
TI  - Creatinine clearance is associated with toxicity from molecularly targeted agents in phase I trials
SN  - 1423-0232
PY  - 2012///1108
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Creatinine
KW  - blood
KW  - Female
KW  - Glomerular Filtration Rate
KW  - Humans
KW  - Kidney Neoplasms
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Prognosis
KW  - Retrospective Studies
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000341152
ER  -